JP2015512403A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015512403A5 JP2015512403A5 JP2015503344A JP2015503344A JP2015512403A5 JP 2015512403 A5 JP2015512403 A5 JP 2015512403A5 JP 2015503344 A JP2015503344 A JP 2015503344A JP 2015503344 A JP2015503344 A JP 2015503344A JP 2015512403 A5 JP2015512403 A5 JP 2015512403A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- composition according
- treatment
- synthetic cationic
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 31
- 125000002091 cationic group Chemical group 0.000 claims 9
- 229920000642 polymer Polymers 0.000 claims 9
- 229920001184 polypeptide Polymers 0.000 claims 9
- 102000004196 processed proteins & peptides Human genes 0.000 claims 9
- 108090000765 processed proteins & peptides Proteins 0.000 claims 9
- 208000015181 infectious disease Diseases 0.000 claims 5
- 230000002265 prevention Effects 0.000 claims 4
- 239000003242 anti bacterial agent Substances 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 206010052428 Wound Diseases 0.000 claims 2
- 208000027418 Wounds and injury Diseases 0.000 claims 2
- 125000000539 amino acid group Chemical group 0.000 claims 2
- 230000000844 anti-bacterial effect Effects 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 238000004659 sterilization and disinfection Methods 0.000 claims 2
- 239000004094 surface-active agent Substances 0.000 claims 2
- 238000002560 therapeutic procedure Methods 0.000 claims 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 1
- 102000004506 Blood Proteins Human genes 0.000 claims 1
- 108010017384 Blood Proteins Proteins 0.000 claims 1
- 102000008186 Collagen Human genes 0.000 claims 1
- 108010035532 Collagen Proteins 0.000 claims 1
- 208000008960 Diabetic foot Diseases 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- 102000009123 Fibrin Human genes 0.000 claims 1
- 108010073385 Fibrin Proteins 0.000 claims 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims 1
- 102000008946 Fibrinogen Human genes 0.000 claims 1
- 108010049003 Fibrinogen Proteins 0.000 claims 1
- 239000002202 Polyethylene glycol Substances 0.000 claims 1
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 1
- 229940072056 alginate Drugs 0.000 claims 1
- 229920000615 alginic acid Polymers 0.000 claims 1
- 235000010443 alginic acid Nutrition 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000002491 angiogenic effect Effects 0.000 claims 1
- 125000000129 anionic group Chemical group 0.000 claims 1
- 239000000058 anti acne agent Substances 0.000 claims 1
- 230000003214 anti-biofilm Effects 0.000 claims 1
- 230000002924 anti-infective effect Effects 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 229940124340 antiacne agent Drugs 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 229940030225 antihemorrhagics Drugs 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 230000004888 barrier function Effects 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 229920001436 collagen Polymers 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 238000009792 diffusion process Methods 0.000 claims 1
- 239000000975 dye Substances 0.000 claims 1
- 230000008029 eradication Effects 0.000 claims 1
- 229950003499 fibrin Drugs 0.000 claims 1
- 229940012952 fibrinogen Drugs 0.000 claims 1
- 239000006260 foam Substances 0.000 claims 1
- 238000009920 food preservation Methods 0.000 claims 1
- -1 food preservation Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 230000023597 hemostasis Effects 0.000 claims 1
- 239000002874 hemostatic agent Substances 0.000 claims 1
- 230000002209 hydrophobic effect Effects 0.000 claims 1
- 239000007943 implant Substances 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 claims 1
- 239000002831 pharmacologic agent Substances 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 239000004814 polyurethane Substances 0.000 claims 1
- 229920002635 polyurethane Polymers 0.000 claims 1
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 1
- 238000004321 preservation Methods 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002947 procoagulating effect Effects 0.000 claims 1
- 230000000770 proinflammatory effect Effects 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 230000001954 sterilising effect Effects 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 238000007910 systemic administration Methods 0.000 claims 1
- 238000010610 time kill assay Methods 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 208000019206 urinary tract infection Diseases 0.000 claims 1
- 210000001215 vagina Anatomy 0.000 claims 1
- 229920002554 vinyl polymer Polymers 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 230000029663 wound healing Effects 0.000 claims 1
- 239000003357 wound healing promoting agent Substances 0.000 claims 1
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261615150P | 2012-03-23 | 2012-03-23 | |
| US61/615,150 | 2012-03-23 | ||
| US201261625757P | 2012-04-18 | 2012-04-18 | |
| US201261625760P | 2012-04-18 | 2012-04-18 | |
| US61/625,760 | 2012-04-18 | ||
| US61/625,757 | 2012-04-18 | ||
| US201261716242P | 2012-10-19 | 2012-10-19 | |
| US61/716,242 | 2012-10-19 | ||
| PCT/US2013/032535 WO2013142374A1 (en) | 2012-03-23 | 2013-03-15 | Compositions and uses of antimicrobial materials with tissue-compatible properties |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017194019A Division JP2018020175A (ja) | 2012-03-23 | 2017-10-04 | 組織適合特性を有する抗菌剤の組成物および使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015512403A JP2015512403A (ja) | 2015-04-27 |
| JP2015512403A5 true JP2015512403A5 (enExample) | 2016-02-04 |
| JP6224069B2 JP6224069B2 (ja) | 2017-11-01 |
Family
ID=49223273
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015503344A Active JP6224069B2 (ja) | 2012-03-23 | 2013-03-15 | 組織適合特性を有する抗菌剤の組成物および使用 |
| JP2017194019A Pending JP2018020175A (ja) | 2012-03-23 | 2017-10-04 | 組織適合特性を有する抗菌剤の組成物および使用 |
| JP2019166236A Active JP7255787B2 (ja) | 2012-03-23 | 2019-09-12 | 組織適合特性を有する抗菌剤の組成物および使用 |
| JP2020184556A Pending JP2021020964A (ja) | 2012-03-23 | 2020-11-04 | 組織適合特性を有する抗菌剤の組成物および使用 |
| JP2022176900A Pending JP2023011850A (ja) | 2012-03-23 | 2022-11-04 | 組織適合特性を有する抗菌剤の組成物および使用 |
| JP2025019121A Pending JP2025065375A (ja) | 2012-03-23 | 2025-02-07 | 組織適合特性を有する抗菌剤の組成物および使用 |
Family Applications After (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017194019A Pending JP2018020175A (ja) | 2012-03-23 | 2017-10-04 | 組織適合特性を有する抗菌剤の組成物および使用 |
| JP2019166236A Active JP7255787B2 (ja) | 2012-03-23 | 2019-09-12 | 組織適合特性を有する抗菌剤の組成物および使用 |
| JP2020184556A Pending JP2021020964A (ja) | 2012-03-23 | 2020-11-04 | 組織適合特性を有する抗菌剤の組成物および使用 |
| JP2022176900A Pending JP2023011850A (ja) | 2012-03-23 | 2022-11-04 | 組織適合特性を有する抗菌剤の組成物および使用 |
| JP2025019121A Pending JP2025065375A (ja) | 2012-03-23 | 2025-02-07 | 組織適合特性を有する抗菌剤の組成物および使用 |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US9446090B2 (enExample) |
| EP (2) | EP4516101A3 (enExample) |
| JP (6) | JP6224069B2 (enExample) |
| KR (2) | KR102266659B1 (enExample) |
| CN (1) | CN104582688A (enExample) |
| AU (2) | AU2013235336B2 (enExample) |
| BR (1) | BR112014023068B1 (enExample) |
| CA (1) | CA2867903C (enExample) |
| ES (1) | ES2991989T3 (enExample) |
| HU (1) | HUE069626T2 (enExample) |
| IN (1) | IN2014DN08299A (enExample) |
| MX (2) | MX378738B (enExample) |
| PL (1) | PL2827841T3 (enExample) |
| RU (1) | RU2680959C2 (enExample) |
| WO (1) | WO2013142374A1 (enExample) |
| ZA (1) | ZA201407121B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0811530B1 (pt) | 2007-05-14 | 2019-01-02 | Research Foundation Of State Univ Of New York | composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície |
| WO2013142374A1 (en) | 2012-03-23 | 2013-09-26 | Amirobe, Inc. | Compositions and uses of antimicrobial materials with tissue-compatible properties |
| US10046137B2 (en) | 2014-02-21 | 2018-08-14 | Avadim Technologies, Inc. | Method for maintenance of urethral catheters |
| AU2015288635B2 (en) * | 2014-07-11 | 2018-07-26 | Menicon Co., Ltd. | Visibility-ensuring material, and device for discharging visibility-ensuring material |
| US10166253B2 (en) | 2014-08-29 | 2019-01-01 | Region Midtjylland | Positively charged co-polymers for use as antimicrobial agents |
| MX2017006657A (es) * | 2014-11-19 | 2018-03-15 | Avadim Tech Inc | Método para la prevención y el tratamiento del acné. |
| EP3606543A4 (en) | 2017-04-06 | 2020-12-16 | Amicrobe, Inc. | COMPOSITIONS AND USES OF LOCALLY APPLIED ANTIMICROBIALS WITH IMPROVED PERFORMANCE AND SAFETY |
| GB201711555D0 (en) * | 2017-07-18 | 2017-08-30 | Kent Innovation & Entpr | Antibacterial compounds |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
| WO2020178865A1 (en) * | 2019-03-04 | 2020-09-10 | Capretto Ehf. | Microbial removal |
| CN109847090B (zh) * | 2019-03-25 | 2021-08-31 | 深圳市康乐美科技有限公司 | 一种具有抗菌、柔软特性的卫生巾 |
| EP3982909A4 (en) | 2019-06-12 | 2023-11-29 | Avadim Health, Inc. | COMPOSITIONS AND METHODS FOR ANTISEPTIC TREATMENT OF BIOFILMS ON MAMMALIAN TISSUE |
| NZ793134A (en) * | 2020-04-08 | 2025-10-31 | Amicrobe Inc | Compositions and uses of locally applied synthetic amino acid polymers for prevention and treatment of viral infections |
| CN112048084A (zh) * | 2020-08-21 | 2020-12-08 | 浙江隆泰医疗科技股份有限公司 | 一种低温交联的聚乙烯醇复合抗菌肽材料的制备方法 |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU595040B2 (en) | 1986-07-01 | 1990-03-22 | Ici Australia Operations Proprietary Limited | Cyclohexane-1, 3-dione herbicides |
| US5636643A (en) | 1991-11-14 | 1997-06-10 | Wake Forest University | Wound treatment employing reduced pressure |
| US6632922B1 (en) | 1998-03-19 | 2003-10-14 | The Regents Of The University Of California | Methods and compositions for controlled polypeptide synthesis |
| US6680365B1 (en) | 1998-03-19 | 2004-01-20 | The Regents Of The University Of California | Methods and compositions for controlled polypeptide synthesis |
| US6686446B2 (en) | 1998-03-19 | 2004-02-03 | The Regents Of The University Of California | Methods and compositions for controlled polypeptide synthesis |
| TW570805B (en) | 1998-09-01 | 2004-01-11 | Hoffmann La Roche | Water-soluble pharmaceutical composition in an ionic complex |
| EP1574210B1 (en) | 1999-02-26 | 2016-04-06 | Novartis Vaccines and Diagnostics, Inc. | Microemulsions with adsorbed macromolecules |
| CA2421683C (en) | 2000-09-28 | 2009-09-15 | Chiron Corporation | Microparticles for delivery of the heterologous nucleic acids |
| US6835536B2 (en) * | 2001-08-21 | 2004-12-28 | Micrologix Biotech Inc. | Antimicrobial cationic peptides and formulations thereof |
| US6818732B2 (en) | 2001-08-30 | 2004-11-16 | The Regents Of The University Of California | Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers |
| JP2003171463A (ja) | 2001-12-06 | 2003-06-20 | Chisso Corp | ポリリジン及びその製造法 |
| US20050074467A1 (en) * | 2002-02-07 | 2005-04-07 | Masaaki Fujita | Contact lens solution |
| EP2359859A1 (en) * | 2002-12-09 | 2011-08-24 | Abraxis BioScience, LLC | Compositions comprising albumin nanoparticles and methods of delivery of pharmacological agents |
| DE602004012269T2 (de) * | 2003-07-11 | 2009-04-30 | Theravance, Inc., South San Francisco | Quervernetzte glycopeptid-cephalosporin-antibiotika |
| WO2005018701A1 (en) * | 2003-08-25 | 2005-03-03 | Kane Biotech Inc. | Synergistic antimicrobial compositions and methods of inhibiting biofilm formation |
| US7314857B2 (en) * | 2003-08-25 | 2008-01-01 | Kane Biotech Inc. | Synergistic antimicrobial compositions and methods of inhibiting biofilm formation |
| CA2550872C (en) | 2003-12-30 | 2016-05-03 | Stig Bengmark | Surface protection of exposed biological tissues |
| ATE381945T1 (de) | 2004-03-12 | 2008-01-15 | Intercell Ag | Verfahren zur solubilisierung von peptid- mischungen |
| ES2613027T3 (es) | 2004-08-18 | 2017-05-22 | Novabiotics Limited | Péptidos antibacterianos |
| AU2006256791B2 (en) * | 2005-06-06 | 2012-01-19 | Novozymes Adenium Biotech A/S | Polypeptides having antimicrobial activity and polynucleotides encoding same |
| US20080139450A1 (en) | 2005-07-01 | 2008-06-12 | Srinivasa Madhyastha | Antimicrobial Compositions and Uses Thereof |
| US20070190110A1 (en) * | 2006-02-10 | 2007-08-16 | Pameijer Cornelis H | Agents and devices for providing blood clotting functions to wounds |
| KR101475447B1 (ko) * | 2006-12-01 | 2014-12-23 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 자기-조립 블록 코폴리머의 베시클 그리고 그것의 제조 및 사용 방법 |
| US20100178320A1 (en) | 2007-06-25 | 2010-07-15 | Lipopeptide Ab | New medical products |
| WO2009032605A2 (en) | 2007-08-27 | 2009-03-12 | Massachusetts Institute Of Technology | Bi-functional polymer-attached inhibitors of influenza virus |
| KR101564796B1 (ko) | 2008-03-10 | 2015-10-30 | 고쿠리츠다이가쿠호우진 도쿄다이가쿠 | 비하전성 친수성 블록 및 측사슬의 일부에 소수성 기가 도입된 카티온성 폴리아미노산 블록을 포함하여 이루어지는 공중합체, 그 사용 |
| EP2292270A1 (en) * | 2008-06-19 | 2011-03-09 | Nippon Shinyaku Co., Ltd. | Drug carrier |
| GB0818074D0 (en) * | 2008-10-02 | 2008-11-05 | Lytix Biopharma As | Treatment of biofilms |
| CN102256613B (zh) * | 2008-10-20 | 2014-09-10 | 莫伊莱麦屈克斯公司 | 用于治疗或者预防粘连的多肽 |
| WO2010083589A1 (en) * | 2009-01-23 | 2010-07-29 | Kane Biotech Inc. | Biofilm-removing antimicrobial compositions and uses thereof |
| GB0905451D0 (en) * | 2009-03-31 | 2009-05-13 | Novabiotics Ltd | Biofilms |
| SG184836A1 (en) * | 2010-04-27 | 2012-11-29 | Lysando Ag | Method of reducing biofilms |
| BR112013004436A2 (pt) * | 2010-08-23 | 2016-06-21 | Amicrobe Inc | composições e usos de materiais com atividade microbicida alta e toxicidade baixa |
| WO2012098653A1 (ja) * | 2011-01-19 | 2012-07-26 | 株式会社メニコン | コンタクトレンズ用液剤 |
| US9781949B2 (en) | 2011-03-31 | 2017-10-10 | The University Of Massachusetts | Antimicrobial delivery systems, methods of manufacture, and methods of use thereof |
| WO2013142374A1 (en) | 2012-03-23 | 2013-09-26 | Amirobe, Inc. | Compositions and uses of antimicrobial materials with tissue-compatible properties |
| DE102014101663A1 (de) | 2014-02-11 | 2015-08-13 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Synthetische artifizielle Peptide mit antimikrobieller Wirkung |
| WO2016044683A1 (en) | 2014-09-19 | 2016-03-24 | Tensive Controls, Inc. | Anti-microbial peptides |
| US20160120936A1 (en) | 2014-10-30 | 2016-05-05 | Karen Troxel | Methods of preventing surgical site infections |
| JP2016113373A (ja) | 2014-12-11 | 2016-06-23 | エスポ化学株式会社 | 抗菌性、抗ウイルス性を有する水溶性組成物 |
| EP3606543A4 (en) | 2017-04-06 | 2020-12-16 | Amicrobe, Inc. | COMPOSITIONS AND USES OF LOCALLY APPLIED ANTIMICROBIALS WITH IMPROVED PERFORMANCE AND SAFETY |
| US20210007999A1 (en) * | 2018-03-02 | 2021-01-14 | January Therapeutics, Inc. | Nanoparticle compositions |
-
2013
- 2013-03-15 WO PCT/US2013/032535 patent/WO2013142374A1/en not_active Ceased
- 2013-03-15 EP EP24200847.2A patent/EP4516101A3/en active Pending
- 2013-03-15 ES ES13764971T patent/ES2991989T3/es active Active
- 2013-03-15 KR KR1020207022133A patent/KR102266659B1/ko active Active
- 2013-03-15 JP JP2015503344A patent/JP6224069B2/ja active Active
- 2013-03-15 PL PL13764971.1T patent/PL2827841T3/pl unknown
- 2013-03-15 HU HUE13764971A patent/HUE069626T2/hu unknown
- 2013-03-15 KR KR1020147029534A patent/KR102141254B1/ko active Active
- 2013-03-15 MX MX2016017289A patent/MX378738B/es unknown
- 2013-03-15 EP EP13764971.1A patent/EP2827841B8/en active Active
- 2013-03-15 AU AU2013235336A patent/AU2013235336B2/en active Active
- 2013-03-15 RU RU2014137827A patent/RU2680959C2/ru active
- 2013-03-15 US US14/385,752 patent/US9446090B2/en active Active
- 2013-03-15 CA CA2867903A patent/CA2867903C/en active Active
- 2013-03-15 IN IN8299DEN2014 patent/IN2014DN08299A/en unknown
- 2013-03-15 BR BR112014023068-4A patent/BR112014023068B1/pt active IP Right Grant
- 2013-03-15 CN CN201380016185.9A patent/CN104582688A/zh active Pending
- 2013-03-15 MX MX2014011237A patent/MX344635B/es active IP Right Grant
-
2014
- 2014-10-01 ZA ZA2014/07121A patent/ZA201407121B/en unknown
-
2016
- 2016-08-18 US US15/240,197 patent/US11298401B2/en active Active
- 2016-11-14 AU AU2016259282A patent/AU2016259282B2/en active Active
-
2017
- 2017-10-04 JP JP2017194019A patent/JP2018020175A/ja active Pending
-
2019
- 2019-09-12 JP JP2019166236A patent/JP7255787B2/ja active Active
-
2020
- 2020-11-04 JP JP2020184556A patent/JP2021020964A/ja active Pending
-
2022
- 2022-03-01 US US17/684,267 patent/US12016898B2/en active Active
- 2022-11-04 JP JP2022176900A patent/JP2023011850A/ja active Pending
-
2024
- 2024-06-20 US US18/749,392 patent/US20250121027A1/en active Pending
-
2025
- 2025-02-07 JP JP2025019121A patent/JP2025065375A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015512403A5 (enExample) | ||
| US12016898B2 (en) | Compositions and uses of antimicrobial materials with tissue-compatible properties | |
| Thattaruparambil Raveendran et al. | Ciprofloxacin-and fluconazole-containing fibrin-nanoparticle-incorporated chitosan bandages for the treatment of polymicrobial wound infections | |
| Sarheed et al. | Antimicrobial dressings for improving wound healing | |
| Bertesteanu et al. | Polymicrobial wound infections: pathophysiology and current therapeutic approaches | |
| KR20120022930A (ko) | 은 설파디아진 및 키토산을 사용하여 제조한 약용 크림 및 이의 제조 방법 | |
| Rathna et al. | Advancements in wound healing: integrating biomolecules, drug delivery carriers, and targeted therapeutics for enhanced tissue repair | |
| JP2020513016A5 (enExample) | ||
| Cetin et al. | Polymer‐and Lipid‐Based Nanostructures Serving Wound Healing Applications: A Review | |
| US20240366717A1 (en) | Antimicrobial matrix formed from peptide hydrogels | |
| Karri et al. | Understanding the implications of pharmaceutical excipients and additives in the treatment of diabetic foot ulcers | |
| Abzaeva et al. | Modern topical hemostatic agents and unique representatives of their new generation | |
| Khan et al. | Emerging Trend of Thiolated Polymers/materials and nanomedicine in wound healing | |
| RU2019103612A (ru) | Композиции и применение противомикробных материалов со свойствами биологической совместимости | |
| Reddy Karri et al. | Understanding the implications of pharmaceutical excipients and additives in the treatment of diabetic foot ulcers. | |
| HK1206614B (en) | Compositions and uses of antimicrobial materials with tissue-compatible properties |